{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:07:00Z","timestamp":1791461220888,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL142768-01"],"award-info":[{"award-number":["R01 HL142768-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL149137-01"],"award-info":[{"award-number":["R01 HL149137-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65344-4","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:53:23Z","timestamp":1763992403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transient overexpression of hPKM2 in porcine cardiomyocytes prevents heart failure after myocardial infarction"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiacheng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Adjmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7339-2207","authenticated-orcid":false,"given":"Rachel C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Anu","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena M.","family":"Z\u0307ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimeen","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Mainkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Lawless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-An","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Soon-Shiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Walcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-366X","authenticated-orcid":false,"given":"Hesham A.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3955-6554","authenticated-orcid":false,"given":"Jianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-9857","authenticated-orcid":false,"given":"Lior","family":"Zangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"65344_CR1","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1136\/hrt.2005.062018","volume":"91","author":"H Dargie","year":"2005","unstructured":"Dargie, H. Heart failure post-myocardial infarction: a review of the issues. Heart 91, ii3\u2013ii6 (2005).","journal-title":"Heart"},{"key":"65344_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1089\/ten.teb.2015.0523","volume":"22","author":"M Domenech","year":"2016","unstructured":"Domenech, M., Polo-Corrales, L., Ramirez-Vick, J. E. & Freytes, D. O. Tissue engineering strategies for myocardial regeneration: acellular versus cellular scaffolds? Tissue Eng. Part B Rev. 22, 438\u2013458 (2016).","journal-title":"Tissue Eng. Part B Rev."},{"key":"65344_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrcardio.2016.36","volume":"13","author":"IY Chen","year":"2016","unstructured":"Chen, I. Y., Matsa, E. & Wu, J. C. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nat. Rev. Cardiol. 13, 333\u2013349 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"65344_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/CIRCRESAHA.120.315855","volume":"126","author":"A Cannata","year":"2020","unstructured":"Cannata, A., Ali, H., Sinagra, G. & Giacca, M. Gene therapy for the heart lessons learned and future perspectives. Circ. Res. 126, 1394\u20131414 (2020).","journal-title":"Circ. Res."},{"key":"65344_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"65344_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med"},{"key":"65344_CR7","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Kariko","year":"2008","unstructured":"Kariko, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"65344_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtn.2018.08.021","volume":"13","author":"A Magadum","year":"2018","unstructured":"Magadum, A. et al. Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration. Mol. Ther. Nucleic Acids 13, 133\u2013143 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"65344_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.119.043067","volume":"141","author":"A Magadum","year":"2020","unstructured":"Magadum, A. et al. Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration. Circulation 141, 1249\u20131265 (2020).","journal-title":"Circulation"},{"key":"65344_CR10","doi-asserted-by":"crossref","unstructured":"Xiao, S. et al. STEMIN and YAP5SA synthetic modified mRNAs regenerate and repair infarcted mouse hearts. J. Cardiovasc. Aging 2, 31 (2022).","DOI":"10.20517\/jca.2022.20"},{"key":"65344_CR11","doi-asserted-by":"crossref","unstructured":"Hadas, Y. et al. Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction. Circulation 141, 916\u2013930 (2020).","DOI":"10.1161\/CIRCULATIONAHA.119.041882"},{"key":"65344_CR12","volume":"8","author":"A Magadum","year":"2021","unstructured":"Magadum, A. et al. Therapeutic delivery of Pip4k2c-modified mRNA attenuates cardiac hypertrophy and fibrosis in the failing heart. Adv. Sci. (Weinh.) 8, 2004661 (2021).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"65344_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.116.022064","volume":"135","author":"L Zangi","year":"2017","unstructured":"Zangi, L. et al. Insulin-like growth factor 1 receptor-dependent pathway drives epicardial adipose tissue formation after myocardial injury. Circulation 135, 59\u201372 (2017).","journal-title":"Circulation"},{"key":"65344_CR14","doi-asserted-by":"crossref","unstructured":"Kaur, K. et al. Direct reprogramming induces vascular regeneration post muscle ischemic injury. Mol. Ther. 29, 3042\u20133058 (2021).","DOI":"10.1016\/j.ymthe.2021.07.014"},{"key":"65344_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.omtm.2018.04.003","volume":"9","author":"L Carlsson","year":"2018","unstructured":"Carlsson, L. et al. Biocompatible, purified VEGF-A mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine. Mol. Ther. Methods Clin. Dev. 9, 330\u2013346 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"65344_CR16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nbt.2682","volume":"31","author":"L Zangi","year":"2013","unstructured":"Zangi, L. et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898\u2013907 (2013).","journal-title":"Nat. Biotechnol."},{"key":"65344_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08852-4","volume":"10","author":"LM Gan","year":"2019","unstructured":"Gan, L. M. et al. Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes. Nat. Commun. 10, 871 (2019).","journal-title":"Nat. Commun."},{"key":"65344_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","volume":"31","author":"V Anttila","year":"2023","unstructured":"Anttila, V. et al. Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting. Mol. Ther. 31, 866\u2013874 (2023).","journal-title":"Mol. Ther."},{"key":"65344_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.113.301075","volume":"113","author":"F Beigi","year":"2013","unstructured":"Beigi, F. et al. C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway. Circ. Res. 113, 372\u2013380 (2013).","journal-title":"Circ. Res."},{"key":"65344_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","volume":"138","author":"K Bersell","year":"2009","unstructured":"Bersell, K., Arab, S., Haring, B. & Kuhn, B. Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138, 257\u2013270 (2009).","journal-title":"Cell"},{"key":"65344_CR21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1101\/gad.1306705","volume":"19","author":"FB Engel","year":"2005","unstructured":"Engel, F. B. et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19, 1175\u20131187 (2005).","journal-title":"Genes Dev."},{"key":"65344_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nm1619","volume":"13","author":"B Kuhn","year":"2007","unstructured":"Kuhn, B. et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 13, 962\u2013969 (2007).","journal-title":"Nat. Med."},{"key":"65344_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature15372","volume":"525","author":"K Wei","year":"2015","unstructured":"Wei, K. et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature 525, 479\u2013485 (2015).","journal-title":"Nature"},{"key":"65344_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.yjmcc.2008.06.006","volume":"45","author":"H Ebelt","year":"2008","unstructured":"Ebelt, H. et al. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice. J. Mol. Cell Cardiol. 45, 411\u2013419 (2008).","journal-title":"J. Mol. Cell Cardiol."},{"key":"65344_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.115.303632","volume":"115","author":"Z Lin","year":"2014","unstructured":"Lin, Z. et al. Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ. Res. 115, 354\u2013363 (2014).","journal-title":"Circ. Res."},{"key":"65344_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/ncb3149","volume":"17","author":"G D\u2019Uva","year":"2015","unstructured":"D\u2019Uva, G. et al. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat. Cell Biol. 17, 627\u2013638 (2015).","journal-title":"Nat. Cell Biol."},{"key":"65344_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458\u2013461 (2011).","journal-title":"Science"},{"key":"65344_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1161\/01.RES.88.4.443","volume":"88","author":"HS Liao","year":"2001","unstructured":"Liao, H. S. et al. Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ. Res. 88, 443\u2013450 (2001).","journal-title":"Circ. Res."},{"key":"65344_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1536\/ihj.50.377","volume":"50","author":"Y Tang","year":"2009","unstructured":"Tang, Y. et al. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J. 50, 377\u2013387 (2009).","journal-title":"Int. Heart J."},{"key":"65344_CR30","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1242\/dev.083774","volume":"139","author":"C Stahlhut","year":"2012","unstructured":"Stahlhut, C., Suarez, Y., Lu, J., Mishima, Y. & Giraldez, A. J. miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish. Development 139, 4356\u20134364 (2012).","journal-title":"Development"},{"key":"65344_CR31","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1172\/JCI33099","volume":"117","author":"E van Rooij","year":"2007","unstructured":"van Rooij, E. & Olson, E. N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J. Clin. Invest 117, 2369\u20132376 (2007).","journal-title":"J. Clin. Invest"},{"key":"65344_CR32","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1161\/CIRCULATIONAHA.120.047211","volume":"142","author":"A Magadum","year":"2020","unstructured":"Magadum, A. et al. Specific modified mRNA translation system. Circulation 142, 2485\u20132488 (2020).","journal-title":"Circulation"},{"key":"65344_CR33","doi-asserted-by":"crossref","unstructured":"Liu, S. et al. Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction. Sci. Transl. Med. 13, eabd6892 (2021).","DOI":"10.1126\/scitranslmed.abd6892"},{"key":"65344_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.119.045116","volume":"142","author":"A Baehr","year":"2020","unstructured":"Baehr, A. et al. Agrin promotes coordinated therapeutic processes leading to improved cardiac repair in pigs. Circulation 142, 868\u2013881 (2020).","journal-title":"Circulation"},{"key":"65344_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCRESAHA.123.322929","volume":"133","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. CCND2 modified mRNA activates cell cycle of cardiomyocytes in hearts with myocardial infarction in mice and pigs. Circ. Res. 133, 484\u2013504 (2023).","journal-title":"Circ. Res."},{"key":"65344_CR36","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ymthe.2017.03.016","volume":"25","author":"N Sultana","year":"2017","unstructured":"Sultana, N. et al. Optimizing cardiac delivery of modified mRNA. Mol. Ther. 25, 1306\u20131315 (2017).","journal-title":"Mol. Ther."},{"key":"65344_CR37","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3929","volume":"49","author":"M Patterson","year":"2017","unstructured":"Patterson, M. et al. Frequency of mononuclear diploid cardiomyocytes underlies natural variation in heart regeneration. Nat. Genet. 49, 1346\u20131353 (2017).","journal-title":"Nat. Genet."},{"key":"65344_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0490-2","volume":"15","author":"N Azoitei","year":"2016","unstructured":"Azoitei, N. et al. PKM2 promotes tumor angiogenesis by regulating HIF-1alpha through NF-kappaB activation. Mol. Cancer 15, 3 (2016).","journal-title":"Mol. Cancer"},{"key":"65344_CR39","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1073\/pnas.101564798","volume":"98","author":"R Cao","year":"2001","unstructured":"Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J. & Cao, Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. USA 98, 6390\u20136395 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65344_CR40","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/CIRCRESAHA.121.319929","volume":"130","author":"H El-Sammak","year":"2022","unstructured":"El-Sammak, H. et al. A Vegfc-Emilin2a-Cxcl8a signaling axis required for zebrafish cardiac regeneration. Circ. Res. 130, 1014\u20131029 (2022).","journal-title":"Circ. Res."},{"key":"65344_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.669188","volume":"9","author":"K Kalra","year":"2021","unstructured":"Kalra, K., Eberhard, J., Farbehi, N., Chong, J. J. & Xaymardan, M. Role of PDGF-A\/B ligands in cardiac repair after myocardial infarction. Front Cell Dev. Biol. 9, 669188 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"65344_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.120.050635","volume":"143","author":"M Rasanen","year":"2021","unstructured":"Rasanen, M. et al. VEGF-B promotes endocardium-derived coronary vessel development and cardiac regeneration. Circulation 143, 65\u201377 (2021).","journal-title":"Circulation"},{"key":"65344_CR43","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen, T. T. et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098\u20131106 (2003).","journal-title":"Circ. Res."},{"key":"65344_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S1525-0016(03)00230-2","volume":"8","author":"K Takahashi","year":"2003","unstructured":"Takahashi, K. et al. Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. Mol. Ther. 8, 584\u2013592 (2003).","journal-title":"Mol. Ther."},{"key":"65344_CR45","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.RES.0000218275.54089.12","volume":"98","author":"NP Brindle","year":"2006","unstructured":"Brindle, N. P., Saharinen, P. & Alitalo, K. Signaling and functions of angiopoietin-1 in vascular protection. Circ. Res. 98, 1014\u20131023 (2006).","journal-title":"Circ. Res."},{"key":"65344_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","volume":"21","author":"A Collen","year":"2022","unstructured":"Collen, A. et al. VEGFA mRNA for regenerative treatment of heart failure. Nat. Rev. Drug Discov. 21, 79\u201380 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"65344_CR47","doi-asserted-by":"crossref","unstructured":"Glinton, K. E. et al. Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation. J. Clin. Investig. 132, e140685\u2013e140685 (2022).","DOI":"10.1172\/JCI140685"},{"key":"65344_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI25878","volume":"116","author":"PC Hsieh","year":"2006","unstructured":"Hsieh, P. C., Davis, M. E., Gannon, J., MacGillivray, C. & Lee, R. T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest 116, 237\u2013248 (2006).","journal-title":"J. Clin. Invest"},{"key":"65344_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.999226","volume":"10","author":"J Pajula","year":"2022","unstructured":"Pajula, J. et al. Adenoviral VEGF-D(DeltaN DeltaC) gene therapy for myocardial ischemia. Front Bioeng. Biotechnol. 10, 999226 (2022).","journal-title":"Front Bioeng. Biotechnol."},{"key":"65344_CR50","doi-asserted-by":"publisher","first-page":"H1265","DOI":"10.1152\/ajpheart.00092.2010","volume":"299","author":"CC Smith","year":"2010","unstructured":"Smith, C. C. et al. Leptin-induced cardioprotection involves JAK\/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am. J. Physiol. Heart Circul. Physiol. 299, H1265\u2013H1270 (2010).","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"key":"65344_CR51","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.161.9.4499","volume":"161","author":"EZ Wolpert","year":"1998","unstructured":"Wolpert, E. Z., Grufman, P., Sandberg, J. K., Tegnesjo, A. & Karre, K. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 161, 4499\u20134505 (1998).","journal-title":"J. Immunol."},{"key":"65344_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","volume":"324","author":"SP Murphy","year":"2020","unstructured":"Murphy, S. P., Ibrahim, N. E. & Januzzi, J. L. Jr. Heart failure with reduced ejection fraction: a review. JAMA 324, 488\u2013504 (2020).","journal-title":"JAMA"},{"key":"65344_CR53","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.rvsc.2011.02.008","volume":"91","author":"LV Sondergaard","year":"2011","unstructured":"Sondergaard, L. V., Dagnaes-Hansen, F. & Herskin, M. S. Welfare assessment in porcine biomedical research\u2014suggestion for an operational tool. Res Vet. Sci. 91, e1\u2013e9 (2011).","journal-title":"Res Vet. Sci."},{"key":"65344_CR54","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.1200708","volume":"331","author":"ER Porrello","year":"2011","unstructured":"Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078\u20131080 (2011).","journal-title":"Science"},{"key":"65344_CR55","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1161\/CIRCULATIONAHA.118.034886","volume":"138","author":"W Zhu","year":"2018","unstructured":"Zhu, W. et al. Regenerative potential of neonatal porcine hearts. Circulation 138, 2809\u20132816 (2018).","journal-title":"Circulation"},{"key":"65344_CR56","doi-asserted-by":"publisher","first-page":"e1000985","DOI":"10.1371\/journal.ppat.1000985","volume":"6","author":"D Huser","year":"2010","unstructured":"Huser, D. et al. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog. 6, e1000985 (2010).","journal-title":"PLoS Pathog."},{"key":"65344_CR57","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/mt.2012.47","volume":"20","author":"A Nowrouzi","year":"2012","unstructured":"Nowrouzi, A. et al. Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver. Mol. Ther. 20, 1177\u20131186 (2012).","journal-title":"Mol. Ther."},{"key":"65344_CR58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"K Gabisonia","year":"2019","unstructured":"Gabisonia, K. et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569, 418\u2013422 (2019).","journal-title":"Nature"},{"key":"65344_CR59","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-020-00499-9","volume":"18","author":"S Sahoo","year":"2021","unstructured":"Sahoo, S., Kariya, T. & Ishikawa, K. Targeted delivery of therapeutic agents to the heart. Nat. Rev. Cardiol. 18, 389\u2013399 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"65344_CR60","doi-asserted-by":"crossref","unstructured":"Zak, M. M. et al. Modified mRNA formulation and stability for cardiac and skeletal muscle delivery. Pharmaceutics 15, 2176 (2023).","DOI":"10.3390\/pharmaceutics15092176"},{"key":"65344_CR61","doi-asserted-by":"crossref","unstructured":"Fukuda, R. et al. Metabolic modulation regulates cardiac wall morphogenesis in zebrafish. Elife 8, e50161 (2019).","DOI":"10.7554\/eLife.50161"},{"key":"65344_CR62","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024854","volume":"11","author":"L Ni","year":"2022","unstructured":"Ni, L. et al. Pyruvate kinase M2 protects heart from pressure overload-induced heart failure by phosphorylating RAC1. J. Am. Heart Assoc. 11, e024854 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"65344_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.prp.2014.10.003","volume":"211","author":"J Shi","year":"2015","unstructured":"Shi, J., Yang, X., Yang, D., Li, Y. & Liu, Y. Pyruvate kinase isoenzyme M2 expression correlates with survival of cardiomyocytes after allogeneic rat heterotopic heart transplantation. Pathol. Res. Pract. 211, 12\u201319 (2015).","journal-title":"Pathol. Res. Pract."},{"key":"65344_CR64","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","volume":"45","author":"X Gao","year":"2012","unstructured":"Gao, X., Wang, H., Yang, J. J., Liu, X. & Liu, Z. R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 45, 598\u2013609 (2012).","journal-title":"Mol. Cell"},{"key":"65344_CR65","doi-asserted-by":"publisher","first-page":"551","DOI":"10.18632\/oncotarget.299","volume":"2","author":"W Luo","year":"2011","unstructured":"Luo, W. & Semenza, G. L. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2, 551\u2013556 (2011).","journal-title":"Oncotarget"},{"key":"65344_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.gendis.2016.11.003","volume":"4","author":"X Lv","year":"2017","unstructured":"Lv, X. et al. The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism. Genes Dis. 4, 19\u201324 (2017).","journal-title":"Genes Dis."},{"key":"65344_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","volume":"9","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. PKM2, function and expression and regulation. Cell Biosci. 9, 52 (2019).","journal-title":"Cell Biosci."},{"key":"65344_CR68","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/ATVBAHA.111.244590","volume":"32","author":"CA Souders","year":"2012","unstructured":"Souders, C. A. et al. c-Myc is required for proper coronary vascular formation via cell- and gene-specific signaling. Arteriosclerosis Thrombosis Vasc. Biol. 32, 1308\u20131319 (2012).","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"key":"65344_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03579-x","volume":"12","author":"J Gu","year":"2021","unstructured":"Gu, J. et al. The role of PKM2 nuclear translocation in the constant activation of the NF-kappaB signaling pathway in cancer-associated fibroblasts. Cell Death Dis. 12, 291 (2021).","journal-title":"Cell Death Dis."},{"key":"65344_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct. Target Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"65344_CR71","doi-asserted-by":"crossref","unstructured":"Zak M. M., Zangi L. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery. Pharmaceutics 13, 1675 (2021).","DOI":"10.3390\/pharmaceutics13101675"},{"key":"65344_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-0716-2707-5_7","volume":"2573","author":"J Yoo","year":"2022","unstructured":"Yoo, J. & Zangi, L. Optimization of synthesis of modified mRNA. Methods Mol. Biol. 2573, 77\u201387 (2022).","journal-title":"Methods Mol. Biol."},{"key":"65344_CR73","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1152\/japplphysiol.00033.2007","volume":"102","author":"J Takagawa","year":"2007","unstructured":"Takagawa, J. et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J. Appl Physiol. (1985) 102, 2104\u20132111 (2007).","journal-title":"J. Appl Physiol. (1985)"},{"key":"65344_CR74","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/CIRCULATIONAHA.120.049497","volume":"144","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction. Circulation 144, 210\u2013228 (2021).","journal-title":"Circulation"},{"key":"65344_CR75","doi-asserted-by":"crossref","unstructured":"Gao, L. et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci. Transl. Med. 12, eaay1318 (2020).","DOI":"10.1126\/scitranslmed.aay1318"},{"key":"65344_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90283-7","volume":"11","author":"M Polacin","year":"2021","unstructured":"Polacin, M. et al. Segmental strain analysis for the detection of chronic ischemic scars in non-contrast cardiac MRI cine images. Sci. Rep. 11, 12376 (2021).","journal-title":"Sci. Rep."},{"key":"65344_CR77","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira, M. D. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105, 539\u2013542 (2002).","journal-title":"Circulation"},{"key":"65344_CR78","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.106.653568","volume":"115","author":"A Schmidt","year":"2007","unstructured":"Schmidt, A. et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115, 2006\u20132014 (2007).","journal-title":"Circulation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65344-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:08:23Z","timestamp":1763996903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65344-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65344"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65344-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L. Zangi is an inventor of Issued patents, titled Cell-specific expression of modRNA (PCT\/US2017\/052035; Issued patents in US, EP, AU, UK, SP, JP), that cover the use of hPKM2 CM SMRTs to promote cardiac repair after MI. All authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All modified mRNA (modRNA) vectors containing genes of interest noted in this paper will be made available to other investigators. My institution and I will adhere to the NIH Grants Policy on Sharing of Unique Research Resources including the \u201cSharing of Biomedical Research Resources: Principles and Guidelines for Recipients of NIH Grants and Contracts\u201d issued in December 1999. Specifically, material transfers will be made with no more restrictive terms than in the Simple Letter Agreement or the UBMTA and without reach-through requirements. Should any intellectual property arise which requires a patent, we would ensure that the technology remains widely available to the research community, in accordance with the NIH Principles and Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}}],"article-number":"10354"}}